Article
Directed Evolution of Genetically Encoded LYTACs for Cell-Mediated Delivery
2023-11-15
Abstract excerpt
Lysosome-targeting chimeras (LYTACs) are a promising therapeutic modality to drive the degradation of extracellular proteins. However, early versions of LYTAC contain synthetic glycopeptides that cannot be genetically encoded. Here we present our designs for a fully genetically encodable LYTAC (GELYTAC), making our tool compatible with integration into therapeutic cells for targeted delivery at diseased sites. To...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d3b86013-5043-5ac7-a589-6113281c4ae2
- DOI
- 10.1101/2023.11.14.567117
